Lortat-Jacob H - Search Results

1

Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease.

Zaferani A, Vivès RR, van der Pol P, Hakvoort JJ, Navis GJ, van Goor H, Daha MR, Lortat-Jacob H, Seelen MA, van den Born J. Zaferani A, et al. J Biol Chem. 2011 Feb 18;286(7):5359-67. doi: 10.1074/jbc.M110.167825. Epub 2010 Dec 6. J Biol Chem. 2011. PMID: 21135110 Free PMC article.

2

The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation.

Sadir R, Forest E, Lortat-Jacob H. Sadir R, et al. J Biol Chem. 1998 May 1;273(18):10919-25. doi: 10.1074/jbc.273.18.10919. J Biol Chem. 1998. PMID: 9556569 Free article.

3

Heparin-aggregated RANTES can be crystallised.

Stura EA, Martin L, Lortat-Jacob H, Vivès R, Vita C. Stura EA, et al. Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 1):1670-3. doi: 10.1107/s0907444902012817. Epub 2002 Sep 26. Acta Crystallogr D Biol Crystallogr. 2002. PMID: 12351884

4

A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization.

Vivès RR, Sadir R, Imberty A, Rencurosi A, Lortat-Jacob H. Vivès RR, et al. Biochemistry. 2002 Dec 17;41(50):14779-89. doi: 10.1021/bi026459i. Biochemistry. 2002. PMID: 12475226

5

Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations.

Ricard-Blum S, Féraud O, Lortat-Jacob H, Rencurosi A, Fukai N, Dkhissi F, Vittet D, Imberty A, Olsen BR, van der Rest M. Ricard-Blum S, et al. J Biol Chem. 2004 Jan 23;279(4):2927-36. doi: 10.1074/jbc.M309868200. Epub 2003 Oct 28. J Biol Chem. 2004. PMID: 14585835 Free article.

6

Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron.

Vivès RR, Lortat-Jacob H, Chroboczek J, Fender P. Vivès RR, et al. Virology. 2004 Apr 10;321(2):332-40. doi: 10.1016/j.virol.2004.01.015. Virology. 2004. PMID: 15051392 Free article.

7

A novel strategy for defining critical amino acid residues involved in protein/glycosaminoglycan interactions.

Vivès RR, Crublet E, Andrieu JP, Gagnon J, Rousselle P, Lortat-Jacob H. Vivès RR, et al. J Biol Chem. 2004 Dec 24;279(52):54327-33. doi: 10.1074/jbc.M409760200. Epub 2004 Oct 12. J Biol Chem. 2004. PMID: 15485868 Free article.

8

Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site.

Vivès RR, Imberty A, Sattentau QJ, Lortat-Jacob H. Vivès RR, et al. J Biol Chem. 2005 Jun 3;280(22):21353-7. doi: 10.1074/jbc.M500911200. Epub 2005 Mar 28. J Biol Chem. 2005. PMID: 15797855 Free article.

9

Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity.

Sarrazin S, Bonnaffé D, Lubineau A, Lortat-Jacob H. Sarrazin S, et al. J Biol Chem. 2005 Nov 11;280(45):37558-64. doi: 10.1074/jbc.M507729200. Epub 2005 Sep 9. J Biol Chem. 2005. PMID: 16155294 Free article.

10

Heparan sulphate proteoglycans and viral vectors : ally or foe?

Vivès RR, Lortat-Jacob H, Fender P. Vivès RR, et al. Curr Gene Ther. 2006 Feb;6(1):35-44. doi: 10.2174/156652306775515565. Curr Gene Ther. 2006. PMID: 16475944 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters